Possible induction of mania or hypomania by atypical antipsychotics: An updated review of reported cases

Journal of Clinical Psychiatry

Volumn 65, Issue 11, 2004, Pages 1537-1545

  Rachid, Fady ^a   Bertschy, Gilles ^a   Bondolfi, Guido ^a   Aubry, Jean Michel ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; CHEMICALLY INDUCED DISORDER; CLINICAL PRACTICE; COMPARATIVE STUDY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PSYCHOSIS; REVIEW; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PSYCHOTIC DISORDERS; RISPERIDONE; SCHIZOPHRENIA;

EID: 16344391809     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n1116     Document Type: Review

References (57)

1. Freeman MP, Stoll AL. Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry 1998;155:12-21 (Pubitemid 28037543)
2. Guille C, Sachs GS, Ghaemi SN. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 2000;61:638-642 (Pubitemid 30728954)
3. Tohen M, Sanger TM, McElroy SL, et al, and the Olanzapine HGEH Study Group. Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 1999;156:702-709
4. Tohen M, Jacobs TG, Grundy SL, et al, for the Olanzapine HGGW Study Group. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2000;57:841-849
5. Berk M, Ichim L, Brook S. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 1999;14:339-343 (Pubitemid 29531382)
6. Zajecka JM, Weisler R, Sachs G, et al. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 2002;63:1148-1155 (Pubitemid 36084060)
7. Ghaemi SN, Sachs GS, Baldassano CF, et al. Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Can J Psychiatry 1997;42:196-199 (Pubitemid 27181951)
8. Ghaemi SN, Sachs GS. Long-term risperidone treatment in bipolar disorder: 6-month follow up. Int Clin Psychopharmacol 1997;12:333-338 (Pubitemid 28133231)
9. Tohen M, Zarate CA Jr, Centorrino F, et al. Risperidone in the treatment of mania. J Clin Psychiatry 1996;57:249-253 (Pubitemid 26230648)
10. Vieta E, Gasto C, Colom F, et al. Treatment of refractory rapid cycling bipolar disorder with risperidone [letter]. J Clin Psychopharmacol 1998;18:172-174 (Pubitemid 28192980)
11. Yatham LN, Binder C, Riccardelli R, et al. Risperidone in acute and continuation treatment of mania. Int Clin Psychopharmacol 2003;18:227-235 (Pubitemid 36871874)
12. Yatham LN, Grossman F, Augustyns I, et al. Mood stabilisers plus risperidone or placebo in the treatment of acute mania: international, double-blind, randomised controlled trial. Br J Psychiatry 2003;182:141-147 (Pubitemid 36177237)
13. Dunayevich E, Strakowski SM. Quetiapine for treatment-resistant mania [letter]. Am J Psychiatry 2000;157:1341
14. Jones M, Huizar K. Quetiapine monotherapy for acute mania associated with bipolar disorder [abstract]. In: New Research Abstracts of the 156th Annual Meeting of the American Psychiatric Association; May 17-22, 2003; San Francisco, Calif. Abstract NR432:162
15. Keck PE Jr, Versiani M, Potkin S, et al. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 2003;160:741-748 (Pubitemid 41079608)
16. Thase ME. What role do atypical antipsychotic drugs have in treatment-resistant depression? J Clin Psychiatry 2002;63:95-103
17. Ostroff RB, Nelson JC. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression. J Clin Psychiatry 1999;60:256-259 (Pubitemid 29193925)
18. Malhi GS, Checkley SA. Olanzapine in the treatment of psychotic depression [letter]. Br J Psychiatry 1999;174:460 (Pubitemid 29232105)
19. Lane H-Y, Chang W-H. Risperidone monotherapy for psychotic depression unresponsive to other treatments [letter]. J Clin Psychiatry 1998;59:624 (Pubitemid 28555428)
20. Rothschild AJ, Bates KS, Boehringer KL, et al. Olanzapine response in psychotic depression. J Clin Psychiatry 1999;60:116-118 (Pubitemid 29104388)
21. Sajatovic M, Mullen JA, Sweitzer DE. Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis. J Clin Psychiatry 2002;63:1156-1163 (Pubitemid 36084061)
22. Aubry JM, Simon AE, Bertschy G. Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases. J Clin Psychiatry 2000;61:649-655 (Pubitemid 30728956)
23. Zolezzi M, Badr MG. Risperidone-induced mania [letter]. Ann Pharmacother 1999;33:380-381
24. Guzelcan Y, de Haan L, Scholte WF. Risperidone may induce mania. Psychopharmacology (Berl) 2002;162:85-86 (Pubitemid 34639562)
25. Fahy S, Fahy TJ. Induction of manic symptoms by novel antipsychotics [letter]. Br J Psychiatry 2000;176:597 (Pubitemid 30353669)
26. Narayan G, Puranik A. Olanzapine-induced mania. Int J Psychiatry Clin Pract 2000;4:333-334 (Pubitemid 32057658)
27. Borysewicz K, Borysewicz W. A case of mania following olanzapine administration [in Polish]. Psychiatr Pol 2000;34:299-306 (Pubitemid 32140362)
28. Lykouras L, Gournellis R, Angelopoulos E. Manic symptoms induced by olanzapine. Eur Neuropsychopharmacol 2001;11:97-98 (Pubitemid 32335551)
29. Henry C, Demotes-Mainard J. Olanzapine-induced mania in bipolar disorders [letter]. J Psychiatry Neurosci 2002;27:200-201 (Pubitemid 34693930)
30. Benazzi F. Quetiapine-associated hypomania in a woman with schizoaffective disorder [letter]. Can J Psychiatry 2001;46:182-183 (Pubitemid 32274674)
31. Atmaca M, Kuloglu M, Buyukbayram A, et al. Quetiapine-associated and dose-related hypomania in a woman with schizophrenia. Eur Psychiatry 2002;17:292-293 (Pubitemid 35168008)
32. Lykouras L, Oulis P, Hatzimanolis J. Manic symptoms associated with quetiapine treatment. Eur Neuropsychopharmacol 2003;13:135-136 (Pubitemid 36313289)
33. Biancosino B, Marmai L, Facchi A, et al. Quetiapine may induce mania: a case report. Can J Psychiatry 2003;48:349-350 (Pubitemid 36841277)
34. Pacchiarotti I, Manfredi G, Kotzalidis GD, et al. Quetiapine-induced mania [letter]. Aust N Z J Psychiatry 2003;37:626
35. Davis R, Risch SC. Ziprasidone induction of hypomania in depression? [letter]. Am J Psychiatry 2002;159:673-674 (Pubitemid 34274958)
36. 2A in mood changes induced by atypical antipsychotics [letter]. J Clin Psychiatry 2002;63:1185-1186
37. Baldassano CF, Ballas C, Datto SM, et al. Ziprasidone-associated mania: a case series and review of the mechanism. Bipolar Disord 2003;5:72-75 (Pubitemid 36621638)
38. Nolan BP, Schulte JJ Jr. Mania associated with initiation of ziprasidone [letter]. J Clin Psychiatry 2003;64:336 (Pubitemid 36457333)
39. Larson MF, Hauser A. Possible ziprasidone-induced mania [letter]. J Am Acad Child Adolesc Psychiatry 2003;42:1012
40. Privitera MR, Maharaj K. Mania from dose-related ziprasidone augmentation of an SSRI [letter]. J Clin Psychiatry 2003;64:1393-1394 (Pubitemid 37490253)
41. Becker D, Grinberg Y, Weizman A, et al. Association between flupenthixol treatment and emergence of manic symptoms. Eur Psychiatry 2002;17:349-352 (Pubitemid 35408106)
42. Kuhn KU, Meyer K, Maier W. Flupenthixol: a partial atypical neuroleptic? [in German]. Fortschr Neurol Psychiatr 2000;68(suppl 1):S38-S41
43. Hertling I, Philipp M, Dvorak A, et al. Flupenthixol versus risperidone: subjective quality of life as an important factor for compliance in chronic schizophrenic patients. Neuropsychobiology 2003;47:37-46 (Pubitemid 36469785)
44. Murphy BP. Amisulpride-induced mania in a patient with schizophrenia [letter]. Br J Psychiatry 2003;183:172 (Pubitemid 36963148)
45. Baker RW, Milton DR, Stauffer VL, et al. Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania. J Affect Disord 2003;73:147-153 (Pubitemid 36044642)
46. Banov MD, Zarate CA Jr, Tohen M, et al. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 1994;55:295-300 (Pubitemid 24265562)
47. Green AI, Tohen M, Patel JK, et al. Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry 2000;157:982-986 (Pubitemid 30412351)
48. Privitera MR, Lamberti JS, Maharaj K. Clozapine in a bipolar depressed patient [letter]. Am J Psychiatry 1993;150:986
49. Ranjan R, Meltzer HY. Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression. Biol Psychiatry 1996;40:253-258 (Pubitemid 26298200)
50. Lane H-Y, Lin Y-C, Chang W-H. Mania induced by risperidone: dose related? [letter] J Clin Psychiatry 1998;59:85-86 (Pubitemid 28141245)
51. Ichikawa J, Ishii H, Bonaccorso S, et al. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 2001;76:1521-1531 (Pubitemid 32198256)
52. Richelson E. Receptor pharmacology of neuroleptics: relation to clinical effects. J Clin Psychiatry 1999;60(suppl 10):5-14 (Pubitemid 29237170)
53. Daniel DG, Zimbroff DL, Potkin SG, et al, and the Ziprasidone Study Group. Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Neuropsychopharmacology 1999;20:491-505
54. Schmidt AW, Lebel LA, Howard HR Jr, et al. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 2001;425:197-201 (Pubitemid 32770067)
55. Rollema H, Lu Y, Schmidt AW, et al. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex. Biol Psychiatry 2000;48:229-237 (Pubitemid 30618995)
56. Schotte A, Janssen PF, Gommeren W, et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 1996;124:57-73 (Pubitemid 26112775)
57. Gefvert O, Lundberg T, Wieselgren IM, et al. D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study. Eur Neuropsychopharmacol 2001;11:105-110